Difference between revisions of "Porocarcinoma"
Jump to navigation
Jump to search
Line 2: | Line 2: | ||
==General== | ==General== | ||
*Malignant counterpart of ''[[poroma]]''. | *Malignant counterpart of ''[[poroma]]''.<ref name=pmid28954110 >{{Cite journal | last1 = Abarzúa | first1 = Á. | last2 = Álvarez-Véliz | first2 = S. | last3 = Moll-Manzur | first3 = C. | title = Concomitant poroma and porocarcinoma. | journal = An Bras Dermatol | volume = 92 | issue = 4 | pages = 550-552 | month = | year = | doi = 10.1590/abd1806-4841.20175719 | PMID = 28954110 }}</ref> | ||
*Very rare ~ most papers are case reports.<ref name=pmid25515648>{{Cite journal | last1 = Riera-Leal | first1 = L. | last2 = Guevara-Gutiérrez | first2 = E. | last3 = Barrientos-García | first3 = JG. | last4 = Madrigal-Kasem | first4 = R. | last5 = Briseño-Rodríguez | first5 = G. | last6 = Tlacuilo-Parra | first6 = A. | title = Eccrine porocarcinoma: epidemiologic and histopathologic characteristics. | journal = Int J Dermatol | volume = 54 | issue = 5 | pages = 580-6 | month = | year = 2015 | doi = 10.1111/ijd.12714 | PMID = 25515648 }}</ref> | *Very rare ~ most papers are case reports.<ref name=pmid25515648>{{Cite journal | last1 = Riera-Leal | first1 = L. | last2 = Guevara-Gutiérrez | first2 = E. | last3 = Barrientos-García | first3 = JG. | last4 = Madrigal-Kasem | first4 = R. | last5 = Briseño-Rodríguez | first5 = G. | last6 = Tlacuilo-Parra | first6 = A. | title = Eccrine porocarcinoma: epidemiologic and histopathologic characteristics. | journal = Int J Dermatol | volume = 54 | issue = 5 | pages = 580-6 | month = | year = 2015 | doi = 10.1111/ijd.12714 | PMID = 25515648 }}</ref> | ||
Line 15: | Line 15: | ||
*Mass or nodule - typically head and neck (40% of cases) or lower extremity (34% of cases).<ref name=pmid28721214/> | *Mass or nodule - typically head and neck (40% of cases) or lower extremity (34% of cases).<ref name=pmid28721214/> | ||
==Microscopic== | |||
Features: | |||
===Images=== | |||
*[Image: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595608/figure/f4/?report=objectonly Eccrine porocarcinoma (nih.gov)].<ref name=pmid28954110/> | |||
==See also== | ==See also== |
Revision as of 04:23, 6 June 2018
Porocarcinoma is a rare malignant skin tumour that has an aggressive behaviour.[1]
General
Clinical - based on meta-analysis of 453 cases:
- No predominance males versus females.
- Aggressive behaviour >30% of cases have metastases at presentation - typically to lymph nodes.
Treatment:
- Surgery,
Gross
- Mass or nodule - typically head and neck (40% of cases) or lower extremity (34% of cases).[1]
Microscopic
Features:
Images
- [Image: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595608/figure/f4/?report=objectonly Eccrine porocarcinoma (nih.gov)].[2]
See also
References
- ↑ 1.0 1.1 Salih, AM.; Kakamad, FH.; Baba, HO.; Salih, RQ.; Hawbash, MR.; Mohammed, SH.; Othman, S.; Saeed, YA. et al. (Aug 2017). "Porocarcinoma; presentation and management, a meta-analysis of 453 cases.". Ann Med Surg (Lond) 20: 74-79. doi:10.1016/j.amsu.2017.06.027. PMID 28721214.
- ↑ 2.0 2.1 Abarzúa, Á.; Álvarez-Véliz, S.; Moll-Manzur, C.. "Concomitant poroma and porocarcinoma.". An Bras Dermatol 92 (4): 550-552. doi:10.1590/abd1806-4841.20175719. PMID 28954110.
- ↑ Riera-Leal, L.; Guevara-Gutiérrez, E.; Barrientos-García, JG.; Madrigal-Kasem, R.; Briseño-Rodríguez, G.; Tlacuilo-Parra, A. (2015). "Eccrine porocarcinoma: epidemiologic and histopathologic characteristics.". Int J Dermatol 54 (5): 580-6. doi:10.1111/ijd.12714. PMID 25515648.